EU External Trade - Lactams, Clobazam (INN) and methyprylon (INN)

Extra-EU sourcing of Lactams, Clobazam (INN) and methyprylon (INN) is highly concentrated. 🇮🇳 India captures 79.2% of imports (€484K), followed by 🇨🇳 China (9.8%). With an HHI of 6444, this Concentrated market exposes the EU to supply dependency risks.

European exports of Lactams, Clobazam (INN) and methyprylon (INN) are concentrated on a few markets. 🇮🇳 India accounts for 40.4% (€12.6M), ahead of 🇧🇷 Brazil (31.8%). The top three destinations are 🇮🇳 India, 🇧🇷 Brazil, 🇯🇵 Japan.

Within the EU, 🇳🇱 Netherlands concentrates 78.9% of Lactams, Clobazam (INN) and methyprylon (INN) imports, well ahead of 🇧🇪 Belgium (9.8%). The top importing member states are 🇳🇱 Netherlands, 🇧🇪 Belgium, 🇩🇰 Denmark.

In 2025, trade flows diverged: imports were falling sharply (-39.5%) while exports were surging (15.4%), signalling a structural market shift.